CorrespondenceSupplementation with cow's milk at birth is not recommended
References (8)
- et al.
Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow's milk allergy: a prospective, randomized study with a follow-up to the age of 2 years
J Pediatr
(2002) - et al.
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy
J Allergy Clin Immunol
(2010) - et al.
Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas
Pediatrics
(2008) - et al.
Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition
J Pediatr Gastroenterol Nutr
(2008)
Cited by (10)
Timing of Cow's Milk Protein Introduction and Childhood Adverse Reactions to Cow's Milk
2022, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :We measured milk-specific IgE levels in mid-childhood on a subset of our sample and did not observe associations of timing of CMPI with milk sensitization or IgE-mediated milk allergy in mid-childhood. There is well-founded concern that suggesting early introduction of cow’s milk for allergy prevention may undermine efforts to promote breast-feeding.35 Our results should not be interpreted as conflicting with recommendations to breast-feed, because breast-feeding is associated with extensive health benefits for the mother and infant.36
Prevention of food allergy - Current recommendations and new opportunities
2015, Pediatria PolskaReply
2011, Journal of Allergy and Clinical ImmunologyBioactive peptides from casein and whey proteins
2014, Milk and Dairy Products as Functional Foods
Disclosure of potential conflict of interest: S. Koletzko receives honoraria for lectures from Nestlé and Danone and is on the advisory board for Mead Johnson. A. von Berg receives honoraria for lectures from Nestlé. C.-P. Bauer receives honoraria from MSD and Nestlé. D. Berdel is on the National Advisory Board for MSD and Novartis. The rest of the authors have declared that they have no conflict of interest.